EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Canocapavir Is a Novel Capsid Assembly Modulator Inducing a Conformational Change of the Linker Region of HBV Core Protein

Yuan Zheng, Le Yang, Lin Yu, Yuanfei Zhu, Yang Wu, Zhijun Zhang, Tian Xia, Qiang Deng

Viruses · 2023

DOI: 10.3390/v15051195 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Yuan Zheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Frontiers Science Center of Pathogenic Microorganisms and Infection, School of …. Hauptthemen laut MEDLINE: Capsid, Hepatitis B. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Municipal Science and Technology Major Project, National Natural Science Foundation grants, CAMS Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Canocapavir is a novel antiviral agent with characteristics of core protein allosteric modulators (CpAMs) that is currently in a phase II clinical trial for treatment of hepatitis B virus (HBV) infection. Herein, we show that Canocapavir prevented the encapsidation of HBV pregenomic RNA and increased the accumulation of cytoplasmic empty capsids, presumably by targeting the hydrophobic pocket at the dimer-dimer interface of HBV core protein (HBc). Canocapavir treatment markedly reduced the egress of naked capsids, which could be reversed by Alix overexpression through a mechanism other than direct association of Alix with HBc. Moreover, Canocapavir interfered with the interaction between HBc and HBV large surface protein, resulting in diminished production of empty virions. Of particular note, Canocapavir induced a conformational change of capsids, with the C-terminus of HBc linker region fully exposed on the exterior of capsids. We posit that the allosteric effect may have great importance in the anti-HBV activity of Canocapavir, given the emerging virological significance of HBc linker region. In support of this notion, the mutation at HBc V124W typically recapitulated the conformational change of the empty capsid with aberrant cytoplasmic accumulation. Collectively, our results indicate Canocapavir as a mechanistically distinct type of CpAMs against HBV infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CapsidHepatitis BHumansVirus AssemblyCapsid ProteinsHepatitis B virusRNAVirus Replication

Stichwörter der Autor:innen

allosteric effectcapsid assemblycore protein allosteric modulatorhepatitis B virushepatitis B virus core proteinviral particle egress

Substanzen

Capsid ProteinsRNA

Autor:innen und Institutionen

  • Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Frontiers Science Center of Pathogenic Microorganisms and Infection, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.
  • Shanghai Institute of Infectious Disease and Biosecurity, Shanghai 200032, China.
  • Shanghai Zhimeng Biopharma, Inc., 1976 Gaoke Middle Road, Suite A-302, Pudong District, Shanghai 201210, China.

Förderung

  • Shanghai Municipal Science and Technology Major Project
  • National Natural Science Foundation grants
  • CAMS Innovation Fund for Medical Sciences

Zitieren

APA

Zheng, Y., Yang, L., Yu, L., Zhu, Y., Wu, Y., Zhang, Z., Xia, T., & Deng, Q. (2023). Canocapavir Is a Novel Capsid Assembly Modulator Inducing a Conformational Change of the Linker Region of HBV Core Protein. Viruses. https://doi.org/10.3390/v15051195

Vancouver

Zheng Y, Yang L, Yu L, Zhu Y, Wu Y, Zhang Z, et al. Canocapavir Is a Novel Capsid Assembly Modulator Inducing a Conformational Change of the Linker Region of HBV Core Protein. Viruses. 2023. doi:10.3390/v15051195

BibTeX
@article{Zheng2023,
  author = {Zheng, Yuan and Yang, Le and Yu, Lin and Zhu, Yuanfei and Wu, Yang and Zhang, Zhijun and Xia, Tian and Deng, Qiang},
  title = {Canocapavir Is a Novel Capsid Assembly Modulator Inducing a Conformational Change of the Linker Region of HBV Core Protein},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15051195}
}
Kostenlos starten →